Tag: $AstraZeneca

AstraZeneca Stock Sinks as Cancer Drug Results Disappoint Investors

American depositary receipts of AstraZeneca were falling Monday after the drugmaker reported disappointing results from a Phase 3 trial of a lung- cancer drug.

AstraZeneca signs $2 billion agreement with Quell to develop cell therapies

AstraZeneca (AZN.L) said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion to develop cell therapies that could cure autoimmune diseases.